Spurring community engagement to ensure the proper implementation of the Three I’s for TB/HIV
Modellers examine the cost-effectiveness of PrEP in Africa
Treatment monitoring: no clear benefit to adding viral load to CD4 or clinical symptoms in Thailand and Africa
Safer sex in the treatment era
No reduction in postnatal death or illness with cotrimoxazole prophylaxis for mothers with HIV
Cervical cancer in women with HIV
Managing kidney disease in people living with HIV
Acute and chronic kidney disease
